
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth,... Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.14 | -10.6060606061 | 1.32 | 1.33 | 1.1 | 1456731 | 1.18337231 | CS |
4 | 0 | 0 | 1.18 | 1.55 | 1.02 | 1858585 | 1.27778523 | CS |
12 | 0.35 | 42.1686746988 | 0.83 | 1.55 | 0.760001 | 1642148 | 1.07826468 | CS |
26 | 0.2499 | 26.8680787012 | 0.9301 | 1.55 | 0.6617 | 1272400 | 0.98225593 | CS |
52 | -0.27 | -18.6206896552 | 1.45 | 1.6 | 0.4993 | 1544504 | 0.92728006 | CS |
156 | -8.5 | -87.8099173554 | 9.68 | 15.195 | 0.4525 | 2081467 | 2.72443257 | CS |
260 | -12.12 | -91.1278195489 | 13.3 | 16.79 | 0.4525 | 1487705 | 4.05216028 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관